Tag: clinical trial

Vivasure Enrolls First Patient in Frontier IV Clinical Trial

GALWAY, Ireland–(BUSINESS WIRE)–Vivasure Medical® (“Vivasure”) is pleased to announce the successful enrollment of the first patient in the Frontier IV clinical study, a non-randomized multicenter international trial, designed to expand the indications of its proprietary PerQseal® large arteriotomy closure technology. The patient was enrolled by Dr. Peter Crean at the […]

Bolton Medical Announces the First Implant of the Relay®Pro Clinical Trial for Treatment of Thoracic Aortic Dissections

Sunrise, Fla, October 3, 2017 – Bolton Medical announced the first patient has been enrolled in the RelayPro FDA Phase II Clinical Trial for Treatment of Acute Complicated Type B Thoracic Aortic Dissections.  This trial will assess the safety and efficacy of RelayPro to treat Type B dissections. Christian Shults, M.D., Cardiothoracic […]

Essential Medical Completes Enrollment In US IDE Trial For The MANTA Large Bore Vascular Closure Device Used Primarily In Percutaneous Heart Valve Replacement Procedures

MALVERN, Pennsylvania, Oct. 2, 2017 /PRNewswire/ — Essential Medical today announced the completion of enrollment in the US pivotal IDE trial of the MANTA large bore vascular closure device. “Our team is thrilled with the enthusiasm of investigators and sites that accelerated MANTA study enrollment,” commented Todd Sorzano, Director of Operations at Essential […]

Medtronic Plans for Renal Denervation Pivotal Trial After New Study Shows Significant Blood Pressure Reductions

Published Simultaneously in The Lancet, the Late-Breaking SPYRAL HTN-OFF MED Study at ESC Successfully Isolates RDN Treatment Effect to Show Compelling Efficacy and Safety of Hypertension Procedure DUBLIN and BARCELONA – August 28, 2017 – Medtronic plc (NYSE:MDT) today announced its intent to move forward with a new renal denervation pivotal trial […]

Bayer (BAY) Release: In Canadian-Led Phase III Clinical Study, Xarelto® When Combined With ASA Significantly Lowered The Combined Risk Of Stroke, Cardiovascular Death, And Heart Attack In Patients With Chronic Coronary Or Peripheral Artery Disease By 24%

  Bleeding rates were low, and while major bleeding was increased, notably, there was no significant increase in intracranial or fatal bleeding1. This combination regimen demonstrated a substantial improvement in net clinical benefit of 20%1. Data from Canadian-led COMPASS study, revealed at ESC Congress 2017, included 27,395 patients globally and […]

BioVentrix Announces First Patient Enrolled In IDE Study Of The Revivent TC Transcatheter Ventricular Enhancement Treatment For Ischemic Cardiomyopathy

SAN RAMON, Calif. and CAMBRIDGE, England, Aug. 21, 2017 /PRNewswire/ — BioVentrix, Inc. a pioneer of technologies and procedures for less invasive treatment of heart failure (HF), today announced enrollment of the first patient in the international arm of the ALIVE pivotal clinical trial. The trial is designed to demonstrate the safety and effectiveness of […]

Abbott Leads Way in First Clinical Trial of Minimally Invasive Clip-Based Repair System for Leaky Tricuspid Heart Valves

ABBOTT PARK, Ill., Aug. 9, 2017 — Abbott today announced that the first patient has been enrolled in a clinical study to evaluate a minimally invasive clip-based repair system for treating people with moderate or severe tricuspid regurgitation (TR), a common condition affecting the right side of the heart. The […]

Intact Vascular Announces Enrollment Of First European Patient In Tack Optimized Balloon Angioplasty II Below The Knee (TOBA II BTK) Clinical Trial With The Tack Endovascular System

WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that its Tack Optimized Balloon Angioplasty II Below the Knee (TOBA II BTK) clinical trial has commenced enrollment in Europe, with the first patient treated by Professor Dr. Marianne Brodmann and Dr. Peter Reif at Medical University Graz, Austria. […]

Metastatic Colorectal Cancer Patients Treated First-line With SIR-Spheres® Y-90 Resin Microspheres More Likely to Become Candidates for Potentially Curative Liver Surgery, REsect Study Shows

NEWS PROVIDED BY Sirtex Medical Limited – 24 May, 2017, 03:09 ET MAINZ, Germany, May 24, 2017 /PRNewswire/ — Surgeons’ blinded assessment of pre- and post-treatment CT scans of patients with previously unresectable colorectal cancer liver metastases treated in the SIRFLOX study presented at 12th Annual European-African HPB meeting Adding selective […]

BioCardia Release: Study Shows Helix Transendocardial Delivery System Enables Greater Myocardial Retention Of Stem Cell Therapy

SAN CARLOS, Calif.–(BUSINESS WIRE)–BioCardia®, Inc. (OTC:BCDA) today announced publication of a study in the International Heart Journal.1 According to the study, delivery of stem cell therapy to the heart using the Helix™transendocardial delivery system results in superior cell delivery than either percutaneous intra-coronary infusion or direct injection in an open […]